Search
for
Sort by
Research 181–210 of 1000+
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Immunologic adverse reactions of β-blockers and the skin (Review)
- Alopecia as an Emerging Adverse Effect Associated With Glucagon-Like Peptide-1 (GLP-1) Receptor Agonists for Weight Loss: A Scoping Review
- Laser-Induced Koebner-Related Skin Reactions: A Clinical Overview
- Diuretics
- Immunological aspects and gender bias during respiratory viral infections including novel Coronavirus disease‐19 (COVID‐19): A scoping review
- SOCS1 and SOCS3 as key checkpoint molecules in the immune responses associated to skin inflammation and malignant transformation
- The pathogenesis of alopecia areata
- Case Report: Bimekizumab for dissecting cellulitis of the scalp
- Symptom management in inflammatory bowel disease
- Canadian Expert Recommendations on Safety Overview and Toxicity Management Strategies for Sacituzumab Govitecan Based on Use in Metastatic Triple-Negative Breast Cancer
- Persistently curly hair phenotype with the use of nivolumab for squamous cell lung cancer
- Platelet-Rich Plasma (PRP) and Adipose-Derived Stem Cell (ADSC) Therapy in the Treatment of Genital Lichen Sclerosus: A Comprehensive Review
- Understanding, recognizing, and managing toxicities of targeted anticancer therapies
- Resolution of paraneoplastic alopecia areata following nivolumab in a patient with metastatic melanoma
- Microscopic polyangiitis secondary to Mycobacterium abscessus in a patient with bronchiectasis: a case report
- Cushings syndrome complicating pemphigoid gestationis
- Janus Kinase inhibitors in dermatology: a review
- Stem cell-based therapies for alopecia areata: a narrative review
- Alopecia Areata: A Review of the Role of Oxidative Stress, Possible Biomarkers, and Potential Novel Therapeutic Approaches
- A Phase 1, Open‐Label Study of the Pharmacokinetics of Ritlecitinib in Children Aged 6–12 Years With Alopecia Areata
- Efficacy of Upadacitinib in Treating Alopecia Areata, Atopic Dermatitis, and Th1 Comorbidities in Pediatric Patients: A Comprehensive Case Series and Literature Review
- Teriflunomida and hair disorders
- Comparative efficacy and safety of JAK inhibitors in the treatment of moderate-to-severe alopecia areata: a systematic review and network meta-analysis
- Alopecia areata-like presentations with mogamulizumab therapy
- A case report and literature review of delayed telogen effluvium after topical imiquimod use in treating a cervical high-grade squamous intraepithelial lesion
- Bioengineered polyester nanoparticles for the synergistic treatment of androgenic alopecia via the suppression of 5α-reductase and knockdown of androgen receptor
- Efficacy of a Complex of 5-Aminolevulinic Acid and Glycyl-Histidyl-Lysine Peptide on Hair Growth
- 277 An open label pilot clinical trial of the JAK inhibitor tofacitinib for alopecia areata
- Biologics and Small Molecules for Inflammatory Nail Disorders: A Narrative Review